Delivery Order SPE2DB20D3103-SPE2DB24FP4J4
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$151K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $48,694.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a medication used in the treatment of human immunodeficiency virus (HIV) infection. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,470.72 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used in the treatment of HIV/AIDS. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $11,981.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used for the treatment of HIV-1 infection. The contract has an ultimate completion date of December 26, 2023 and is a firm fixed-price agreement. It is not designated as a set-aside contract, indicating...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,678.28 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used to treat HIV. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,417.77, is for the supply of Biktarvy 50-200-25 mg tablets, a medication used in the treatment of HIV. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,326.01 delivery order contract, awarded by the Defense Logistics Agency (DLA), is for the supply of the HIV medication BIKTARVY 50-200-25 MG TABLET. The contract has a firm fixed price and runs through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,358.78 firm fixed price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a medication used to treat HIV infections. The award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order for the pharmaceutical drug BIKTARVY, a combination tablet for the treatment of HIV. The contract has a total ceiling value of $24,703.99 and is awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed-price pricing type and an ultimate completion date of February 19, 2025. This contract is not designated with a set-aside requirement....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $11,372.48 and a completion date of November 16, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $64,726.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,551,030 units of the HIV medication BIKTARVY 50-200-25 mg tablet. The contract has an ultimate completion date of August 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...